Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Baxter
Merck
Dow
Medtronic
Moodys
Mallinckrodt

Last Updated: May 27, 2022

CLINICAL TRIALS PROFILE FOR SULFUR HEXAFLUORIDE LIPID-TYPE A MICROSPHERES


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Sulfur Hexafluoride Lipid-type A Microspheres

Trial ID Title Status Sponsor Phase Start Date Summary
NCT03040323 ↗ Prospective Analysis of Value of Contrast-enhanced Sonography During Biopsies of Focal Liver Masses Terminated Indiana University Phase 4 2016-12-22 The investigators plan to compare complication and success rates between two methods of ultrasound guidance for biopsy of liver lesions, contrast-enhanced and the current protocol without contrast.
NCT03300401 ↗ Contrast-Enhanced Ultrasound in Diagnosing Patients With Liver Cancer Undergoing Yttrium-90 Radioembolization Withdrawn National Cancer Institute (NCI) N/A 2017-11-07 This pilot clinical trial studies how well contrast-enhanced ultrasound in diagnosing patients with liver cancer who are undergoing Yttrium-90 radioembolization. Contrast-enhanced ultrasound may provide detailed imaging of the tumor arteries after the injection of a contrast-agent consisting of microbubbles, and may predict how much Yttrium-90 will deposit in the tumor.
NCT03300401 ↗ Contrast-Enhanced Ultrasound in Diagnosing Patients With Liver Cancer Undergoing Yttrium-90 Radioembolization Withdrawn University of Southern California N/A 2017-11-07 This pilot clinical trial studies how well contrast-enhanced ultrasound in diagnosing patients with liver cancer who are undergoing Yttrium-90 radioembolization. Contrast-enhanced ultrasound may provide detailed imaging of the tumor arteries after the injection of a contrast-agent consisting of microbubbles, and may predict how much Yttrium-90 will deposit in the tumor.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Sulfur Hexafluoride Lipid-type A Microspheres

Condition Name

Condition Name for Sulfur Hexafluoride Lipid-type A Microspheres
Intervention Trials
Hepatocellular Carcinoma 2
Hypoxic-Ischemic Encephalopathy 1
Liver Biopsy 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Sulfur Hexafluoride Lipid-type A Microspheres
Intervention Trials
Carcinoma, Hepatocellular 2
Carcinoma 2
Liver Diseases 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Sulfur Hexafluoride Lipid-type A Microspheres

Trials by Country

Trials by Country for Sulfur Hexafluoride Lipid-type A Microspheres
Location Trials
United States 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Sulfur Hexafluoride Lipid-type A Microspheres
Location Trials
Pennsylvania 3
Indiana 2
Missouri 1
Texas 1
California 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Sulfur Hexafluoride Lipid-type A Microspheres

Clinical Trial Phase

Clinical Trial Phase for Sulfur Hexafluoride Lipid-type A Microspheres
Clinical Trial Phase Trials
Phase 4 2
Phase 3 3
Phase 2 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Sulfur Hexafluoride Lipid-type A Microspheres
Clinical Trial Phase Trials
Recruiting 4
Completed 1
Terminated 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Sulfur Hexafluoride Lipid-type A Microspheres

Sponsor Name

Sponsor Name for Sulfur Hexafluoride Lipid-type A Microspheres
Sponsor Trials
Children's Hospital of Philadelphia 3
Indiana University 2
National Cancer Institute (NCI) 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Sulfur Hexafluoride Lipid-type A Microspheres
Sponsor Trials
Other 8
Industry 2
NIH 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Medtronic
Mallinckrodt
Johnson and Johnson
AstraZeneca
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.